160552-54-5,
4-amino-1-[(2S,5R)-2-(hydroxymethyl)-3-oxo-1,3-oxathiolan-5-yl]pyrimidin-2-one,
AC1L9Q0R,
1-(2-Hydroxymethyl-3-oxo-1,3-oxathiolan-5-yl)-cytosine,
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl]-, (2a,5a)-,
Lamivudine sulfoxide,
Lamivudine impurity H,
1,3-oxathiolane deriv.,
Lamivudine EP Impurity H,
UNII-3SN4QFF34D,
Lamivudine impurity H [EP],
Lamivudine sulfoxide, (R)-,
Lamivudine impurity H [USP],
Lamivudine impurity H RS [USP],
CID452020,
CS-O-13675,
GI-138870X,
4-amino-1-[(2R,3R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one-S-oxide,
2(1H)-Pyrimidinone, 4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)-,
2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, S-oxide, (2R-(2alpha,3beta,5alpha))-,